Viking Therapeutics: A Wide-Open Oral GLP-1 Market
IT may be dark horse of 2026; realty, pharma and capex also in focus: Sunil Subramaniam
Nifty IT could emerge as a contrarian winner in 2026 as rupee depreciation, AI-led consulting demand and expected Fed rate cuts boost earnings, says Sunil Subramaniam. He also sees strong recovery potential in real estate, GLP-1 driven pharma growth and a renewed private-sector capex cycle shaping market leadership next year.
Older Americans are quitting GLP-1 weight-loss drugs for 4 key reasons
GLP-1 medications have dominated the weight-loss landscape this year — but some older Americans are reportedly kicking the trend to the curb. A study published in JAMA in January 2025 — which looked at more than 125,000 overweight or obese people — found that nearly 47% of those with type 2 diabetes and 65% of […]
The WHO learned to love ‘anti-obesity’ jabs in 2025. I don’t fully agree, but I get it | Devi Sridhar
While GLP-1 drugs promise an easy fix, our bodies still need what they have always needed: healthy food and regular exercise Prof Devi Sridhar is chair of global public health at the University of Edinburgh If there has been a hot topic in health in 2025, it’s definitely been GLP-1s, colloquially referred to as “anti-obesity” […]
Novo and Lilly Cut Prices Of Weight-loss Drugs in China
Novo Nordisk and Eli Lilly are lowering prices of their top-selling obesity drugs Wegovy and Mounjaro in China, according to the Danish drugmaker and Chinese drug… Reuters Health Information
What to Expect on GLP-1s: Typical Side Effects and Symptoms
If you’re starting a GLP-1 medication or have recently begun treatment, you’re probably wondering what to expect. Maybe you’ve heard stories about intense nausea or you’re currently having digestive issues and wondering if what you’re feeling is normal. Here’s the reality: many people do experience side effects, particularly in the early weeks, and while these […]
Oprah Winfrey admits she drank 17 shots of tequila in one night before giving up alcohol due to GLP-1
Oprah Winfrey is opening up about her weight-loss journey. During a recent interview with People magazine, the 71-year-old television personality discussed her new book, “Enough,” which she co-wrote with obesity expert Dr. Ania M. Jastreboff, which details her journey with obesity, saying “I feel more alive and more vibrant than I’ve ever been.” “I feel […]
Science in 2025: the best of the rest
A review of 2025’s noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
Could This Potential Move Boost Eli Lilly’s Prospects?
Everything seems to be going well for Eli Lilly (NYSE: LLY). The company’s shares have soared in recent years thanks to strong clinical progress within its GLP-1 franchise. The drugmaker has established itself as a leader in the fast-growing market for weight loss medicines, and with several exciting pipeline candidates in development, it could extend […]
A Look Back at 2025: Progress Towards the Treatment of Aging as a Medical Condition
As 2025 winds to a close, it is time once again to look back at some of the aging and longevity research published in the past year. Matters do move forward, even in tough times. The research community continues to turn out interesting new papers, the XPRIZE Healthspan competition reached 100 participating teams, and the […]